Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alternatively activated neutrophils limit T cell-driven neuroinflammation.

Journal of neuroinflammation·2026
Same author

Differential sex-dependent responses of circulating steroid hormones and cortical gene expression in a preclinical traumatic brain injury model.

bioRxiv : the preprint server for biology·2026
Same author

Characterization of indoor particulate matter by home heating fuel type in rural New Hampshire homes.

Air quality, atmosphere, & health·2025
Same author

Four-year community-wide PM<sub>2.5</sub> exposure characterization using a low-cost sensor network in a rural valley influenced by residential wood smoke.

Atmospheric environment (Oxford, England : 1994)·2025
Same author

Thinning Antarctic glaciers expose high-altitude nunataks delivering more bioavailable iron to the Southern Ocean.

Nature communications·2025
Same author

Restoring a critically endangered grassland orchid by co-planting to improve pollination and selecting sites based on pollinator availability.

Frontiers in plant science·2025

Related Experiment Video

Updated: Jun 24, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Interferon-alpha causes neuronal dysfunction in encephalitis.

Andrew R Sas1, Heather Bimonte-Nelson, C Thetford Smothers

  • 1Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|March 27, 2009
PubMed
Summary
This summary is machine-generated.

Interferon-alpha (IFNalpha) drives neuroinflammation and cognitive decline in HIV-associated dementia models. Blocking IFNalpha with neutralizing antibodies (NAbs) improved cognition and reduced brain damage in mice.

More Related Videos

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Related Experiment Videos

Last Updated: Jun 24, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses
09:07

Mouse Footpad Inoculation Model to Study Viral-Induced Neuroinflammatory Responses

Published on: June 14, 2020

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

Area of Science:

  • Neuroimmunology
  • Neurovirology
  • Cytokine signaling

Background:

  • Interferon-alpha (IFNalpha) is implicated in cognitive impairment seen in HIV-associated dementia (HAD).
  • Elevated IFNalpha levels in cerebrospinal fluid (CSF) correlate with dementia in HIV patients.
  • IFNalpha is a key mediator of neuroinflammation and neuronal damage.

Purpose of the Study:

  • To investigate the role of IFNalpha in HIV encephalitis (HIVE) pathogenesis.
  • To evaluate the therapeutic potential of blocking IFNalpha in a HIVE mouse model.

Main Methods:

  • Utilized a HIVE mouse model treated with IFNalpha neutralizing antibodies (NAbs).
  • Assessed cognitive function using the water radial arm maze.
  • Examined brain tissue for microgliosis and dendritic arborization.
  • Investigated IFNalpha's direct effects on primary neuron cultures.

Main Results:

  • IFNalpha NAbs significantly improved cognitive function in HIVE mice.
  • Treatment reduced microgliosis and prevented dendritic loss in HIVE mouse brains.
  • IFNalpha induced dose-dependent dendritic arborization loss in neurons, partially mediated by glutamate signaling.

Conclusions:

  • IFNalpha plays a critical role in HIVE pathogenesis and neurocognitive dysfunction.
  • Blocking IFNalpha offers a potential therapeutic strategy for HAD.
  • Targeting IFNalpha may benefit other neuroinflammatory diseases.